BioCentury
ARTICLE | Clinical News

CaloMist cyanocobalamin regulatory update

August 6, 2007 7:00 AM UTC

FDA approved an NDA from Fleming for CaloMist cyanocobalamin to maintain vitamin B-12 concentrations after normalization with intramuscular vitamin B-12 therapy in patients who have no nervous system ...